Crescent Biopharma, Inc. SEC filings CBIO

Crescent Biopharma, Inc. has 676 filings in SEC EDGAR's recent list, going back to Jul 10, 2003. Its latest annual report, Form 10-K, was filed on Feb 26, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Jul 30, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 15, 2026 (other events). The company's fiscal year ends on December 31.

Form Description Filed Period
10-K Annual report Feb 26, 2026 Dec 31, 2025
10-K Annual report Feb 13, 2025 Dec 31, 2024
ARS Annual report to shareholders Apr 1, 2024 Dec 31, 2023
10-K Annual report Mar 27, 2024 Dec 31, 2023
ARS Annual report to shareholders Apr 21, 2023 Dec 31, 2022
10-K Annual report Mar 29, 2023 Dec 31, 2022
10-K Annual report Mar 3, 2022 Dec 31, 2021
10-K Annual report Mar 2, 2021 Dec 31, 2020
10-K Annual report Feb 28, 2020 Dec 31, 2019
10-K Annual report Mar 6, 2019 Dec 31, 2018
10-K Annual report Mar 6, 2018 Dec 31, 2017
10-K Annual report Mar 1, 2017 Dec 31, 2016
10-K Annual report Feb 29, 2016 Dec 31, 2015
10-K Annual report Mar 16, 2015 Dec 31, 2014
10-K Annual report Mar 31, 2014 Dec 31, 2013

Showing 15 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
CBIO (Nasdaq)
Fiscal year ends
December 31
Incorporated in
Cayman Islands
Headquarters
Waltham, MA
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1253689
Former names
GLYCOMIMETICS INC (until Jun 23, 2025)

Other Pharmaceutical Preparations companies

All 570 Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.